The need for total artificial heart devices is growing
as life threatening heart diseases are increasing and the number of heart
donors is decreasing. Total artificial heart is a medical device that provides
mechanical circulatory support and replaces both ventricles of the heart.
Companies and medical teams around the world are developing different types of
artificial hearts that have been implanted in patients since 1969. Almost all
of these artificial hearts are used as a bridge to human heart transplantation.
But destination therapy for total artificial heart is under investigation. For
instance, FDA approved two artificial hearts manufactured by SynCardia and
AbioCor companies. In March 2015, FDA also approved an investigational study
for new smaller SynCardia Total Artificial Heart.
THE BUSINESS RESEARCH COMPANY EXPECTS THE CARDIOVASCULAR DEVICES
MARKET TO GROW TO $60 BILLION BY 2021
Asia Pacific was the largest region in the
cardiovascular devices market in 2017, accounting for one-third of the market
share.
Read report: https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report-2018
According to The Business Research Company’s Consultant, Nitin
Gianchandani, using 3-D printed organs for
pre-planning complex surgeries is gaining popularity and wider acceptance from
many doctors and hospitals after a string of highly successful operations. 3-D
printed organs help doctors to plan entire surgical procedure before the
operations and also helps in significantly reducing the time required to
perform surgery and often eliminates unexpected complications. In March 2016,
Chinese doctors successfully performed an open heart surgery for a nine month
old baby suffering from a severe heart defect by using a fully-sized 3D printed
heart model to pre-plan a complicated surgery.
Medtronic plc was the largest competitor with 18.8% of
the market share, generating revenues of $10.5 billion for the financial year
2016. Medtronic’s growth strategy is to capture untapped business opportunities
in emerging markets through acquisitions. For instance, In January 2015,
Medtronic acquired Covidien Plc for $49.9 Billion in cash. This deal gives
Medtronic the Covidien’s portfolio of cardiac and vascular devices, hospital
supplies from surgical staplers to ventilators, adding size and scope to help
it compete with Johnson & Johnson, a leading medical device company.
Cardiovascular devices are designed to diagnose,
prevent, monitor and treat diseases related to the cardiovascular system,
including heart diseases and related health problems. They include arrhythmia
detectors, noninvasive blood pressure measurement systems, diagnostic
intravascular catheters, external cardiac compressors, coronary vascular
physiologic simulation software devices, external programmable pacemaker pulse
generators, cardiac monitors, cardiopulmonary bypass defoamers,
echocardiographs, vascular graft prostheses, electrocardiographs,
defibrillators and others.
Cardiovascular Devices Global Market Report 2018 is a detailed report giving a unique insight into this
market. The report is priced at $4000 for an individual user. To use across
your office, the price is $6000 and $8000 if you wish to use across a
multinational company.
About The
Business Research Company.
Visit TheBusinessResearchCompany.com,
mail info@tbrc.info or call +447443439350 or +918897263534 or +919160996838 for
more information on this and many other titles.
The Business Research Company is a
market research and intelligence company, which excels in company, market and
consumer research.
It has research professionals at its
offices in the UK, India and the US as well a network of trained researchers
globally. It has specialist consultants in a wide range of industries including
manufacturing, healthcare, chemicals and technology.
The Business Research Company's
management has more than 20 years of varied business research experience. They have
delivered hundreds of research projects to the senior management of some of the
world's largest organizations.
Contact
Information.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment